House Speaker Nancy Pelosi is reportedly readying a plan that could limit Americans’ access to lifesaving medicines and impede the development of new treatments for deadly and debilitating diseases. Her plan, a summary of which was leaked last week, would double down on the failures of existing government policies that have contributed to higher health care costs. It would … [Read more...] about Why Pelosi’s Drug Price Control Scheme Is a Prescription for Disaster
Published
Transparency in Health Care Prices
To the [NY Times] Editor: Re “Four Key Things You Should Know About Health Care” (Op-Ed, nytimes.com, Sept. 12): Ezekiel J. Emanuel and Victor R. Fuchs argue that price transparency won’t lower health care costs. Fortunately, they’re wrong, largely because they missed several avenues for how transparency will help. Transparency should lower prices through four critical paths: better … [Read more...] about Transparency in Health Care Prices
Good and Bad Ideas in the Senate’s Medicare Drug Bill
Responding to popular anxiety over prescription drug prices, the Senate Finance Committee last month approved a bill to restructure the Medicare prescription drug benefit. The bill is part of broader congressional and administration efforts to address rising health care costs, one in which lawmakers are laying aside partisan differences to seek constructive solutions. The … [Read more...] about Good and Bad Ideas in the Senate’s Medicare Drug Bill
ObamaCare’s Medicaid Deception
Galen Senior Fellow Brian Blase reports in a Wall Street Journal op-ed about millions of working, middle-income people being illegally enrolled in Medicaid, the health program designed for poor and vulnerable Americans. Brian and Cato senior fellow Aaron Yelowitz write about new research exposing “ObamaCare’s Medicaid Deception:” ObamaCare is supposed to make Medicaid available to … [Read more...] about ObamaCare’s Medicaid Deception
New Scholar Joins Galen Institute, Pens WSJ Piece!
The Galen Institute is delighted to announce that former presidential advisor Brian Blase is joining the Galen Institute as a Senior Fellow. Until last month, Brian served on the White House’s National Economic Council where he succeeded in implementing important health policy initiatives, including Health Reimbursement Arrangements, Short-Term Limited-Duration Health Plans, Association … [Read more...] about New Scholar Joins Galen Institute, Pens WSJ Piece!
Budget Deal Landmines
Published on FORBES.com | The Trump administration and the Congress reportedly are close to a budget deal that would increase federal spending and also suspend the debt limit for two years. House Speaker Nancy Pelosi is personally engaged in the talks in an effort to reach a deal before the Congress leaves town for its August recess. As a sweetener, she says she will … [Read more...] about Budget Deal Landmines
A Spectacular Celebration!
Published on FORBES.com | The July 4 Salute to America was a thrilling, awe-inspiring celebration of America’s greatness. Jaws dropped from the first minute as Air Force One soared low over the Lincoln Memorial just as President Trump and the First Lady stepped onto the stage. The hot, muggy, rainy weather did nothing to dampen the spirits of the crowd who, like me, surely have … [Read more...] about A Spectacular Celebration!
New Administration Action Could Give 11 Million Workers More Health Insurance Options
Published on FORBES.com | The Trump administration finalized a new rule late today that offers important opportunities for businesses, especially small employers, to offer more health coverage options for their workers and for employees to have much more flexibility and control over their health care dollars. The rule undoes an Obama administration action that forbade workers … [Read more...] about New Administration Action Could Give 11 Million Workers More Health Insurance Options